Novartis joins CureVac's vaccine contractor line-up
Slideshow ( 2 images )FRANKFURT (Reuters) – German biotech firm CureVac has enlisted Swiss pharmaceutical giant Novartis to help produce
Read more
Slideshow ( 2 images )FRANKFURT (Reuters) – German biotech firm CureVac has enlisted Swiss pharmaceutical giant Novartis to help produce
Read moreSlideshow ( 2 images )ZURICH (Reuters) – Novartis has entered into a grant agreement with the Bill & Melinda Gates
Read moreEAST HANOVER, N.J., Dec. 8, 2020 /PRNewswire/ — Detailed results from the Phase III ASCEMBL study demonstrate that, at 24 weeks, asciminib (ABL001)
Read moreEAST HANOVER, N.J., Nov. 13, 2020 /PRNewswire/ — Novartis today announced results from two pooled post-hoc analyses of Phase III ORION-9, -10 and
Read more